Navigation Links
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Date:4/1/2008

CHICAGO, April 1, 2008 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today announced new data presented at the 57th Annual Scientific Sessions of the American College of Cardiology shows that Ranexa(R) (ranolazine extended release tablets) significantly reduced the risk of recurrent ischemia (p=0.002), worsening angina (p=0.048) and intensification of antianginal therapy (p=0.009) in angina patients (n=3,565) in the MERLIN- TIMI 36 study.

Additionally, Ranexa significantly improved all measures of exercise performance compared to placebo, including reductions in the time to onset of angina (p=0.002) and time to the onset of 1 mm ST segment depression (p=0.002), a signal of ischemia, in these MERLIN-TIMI 36 angina patients.

"MERLIN-TIMI 36 is the largest study of ranolazine in patients with established coronary artery disease," said David Morrow, M.D., MPH, of Brigham & Women's Hospital at Harvard Medical School and lead investigator of the MERLIN-TIMI 36 study. "This new subgroup analysis shows consistent safety and efficacy across a broader group of angina patients than those studied previously and reaffirms ranolazine as an option for treating chronic angina."

Study Design

MERLIN-TIMI 36 (Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes) was a multi-national, double-blind, randomized, placebo-controlled, parallel-group clinical trial designed to evaluate the efficacy and safety of Ranexa during acute and long-term treatment in 6,560 patients (3,279 received ranolazine, 3,281 received placebo) with non-ST elevation ACS treated with standard therapy.

Previously published data from the MERLIN-TIMI 36 study has shown that Ranexa was safe i
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
2. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
3. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
4. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
5. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
6. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
7. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
10. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
11. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... that it will present at the Deutsche Bank 38 th ... at 10:40 a.m. (ET). A live webcast ... website at www.bd.com/investors and will be available for ... BD BD is a leading global medical technology ...
(Date:5/24/2013)... -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading ... Dr. Robert Grieve , the Company,s chairman ... , executive vice president and chief financial officer, will present ... held May 30, 2013 in New York City ... The Company,s presentation is scheduled to begin at 1:30 p.m. ...
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
... DecisionView Inc., a leading provider of ... life sciences companies, today announced the release of ... flagship solution for patient enrollment planning, tracking and ... into site performance and cost projections, StudyOptimizer 4.3 ...
... 19, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
Cached Medicine Technology:DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 2DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 3North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6
(Date:5/25/2013)... 25 (HealthDay News) -- Animals make great companions for senior ... in the car are far more likely to crash than ... The new study included 2,000 licensed drivers aged 70 ... asked how often they drove with their pet in the ... the crash risk was twice as high as among those ...
(Date:5/25/2013)... Studies from Johns Hopkins University reveal a direct ... their inability to get adequate sleep. These same studies ... relieve many symptoms. , Johns Hopkins University School ... significantly associated with overall weight loss, especially belly fat. ... 6th, 2012, researchers monitored 77 participants who were diabetic ...
(Date:5/25/2013)... May 25, 2013 On May 20, 2013 ... do not wish to discuss or plan for their eventual ... FuneralFinancials.com released a Must-Do List to help people ... Financials recommends, “Creating a personal fact sheet.” , While not ... financial information and personal data. It may include a ...
(Date:5/25/2013)... By working diligently for months on ... of the 2012 Lamborghini Aventador into their well-built fitments ... in the list of vehicles lined by SizeItUp for ... set to thrill automobile lovers in the year 2013. ... looks, the 2012 Lamborghini Aventador comes with extraordinarily spacious ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office ... is. Most people would naturally assume that the ... cloud service and support would own and maintain all ... they'd be wrong. Cloud providers lease space in ... that houses servers and related equipment to run cloud ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
... School of Public Health (HSPH) have found that children ... laws promoting smoke-free public places have significantly lower levels ... those living in counties with no smoke-free laws. ... with smoke-free laws had 39% lower prevalence of cotinine ...
... June 5 Patients undergoing treatment for melanoma that ... chemotherapy delivered directly into the liver,s blood vessels, according ... and Delcath Systems Inc., and led by James F. ... School of Medicine, and surgical oncologist with UPMC Cancer ...
... Studies show combo chemotherapy, new drug prolonged lives of ... News) -- Researchers report they prolonged survival for some ... the median survival is currently only about six months. ... called crizotinib shrank tumors in the majority of lung ...
... millions in hopes of protection against cancer and a host ... in reducing a patient,s risk of developing lung cancer - ... of an international Phase III clinical trial. Results from ... were presented today at the American Society of Clinical Oncology ...
... ... J. Brueck MD FACS, Fort Myers cosmetic surgeon, has applied stem cell therapy ... exist in a person’s fat. It can be harvested and spun down. It ... PRP is the result of the blood being spun down to create a ...
... ... the Savory Institute and the Africa Centre for Holistic Management are winning awards for their ... rivers back to life, increase food production and security and store carbon in ever deeper ... (PRWEB) ...
Cached Medicine News:Health News:Smoke-free air laws effective at protecting children from secondhand smoke 2Health News:New treatment method safe, effective for advanced melanoma patients 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Selenium shows no benefit in prevention of lung cancer 2Health News:Selenium shows no benefit in prevention of lung cancer 3Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 2Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 3Health News:Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change. 2
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... a layered design unique in the industry. ... prevent stray electrosurgical burns along the shaft ... or capacitive coupling; a well-documented patient safety ... AEM Instruments provides a neutral return path ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: